Skip to content
Disclosery

GENERAL ATLANTIC, L.P.

Follow

13F filer, CIK 1017645, New York, NY

GENERAL ATLANTIC, L.P. reported $2,979,034,194 across 15 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-14. Its ten largest share positions make up 98.5% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-25-001365

Period
2025-03-31
Reported value
$2.98B
Holdings
15
Top 10 weight
98.5%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
THRDexited-3,372,323-$34.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0000950142-25-001365, largest first. % of portfolio is the value over $2,979,034,194, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,993,323 shares; 2024Q4: 60,993,323 shares; 2025Q1: 60,993,323 shares 60,993,323$1.14B38.12%0Timeline
DLODLOCAL LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 63,906,695 shares; 2024Q4: 63,906,695 shares; 2025Q1: 63,906,695 shares 63,906,695$533M17.89%0Timeline
XPXP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 29,617,733 shares; 2024Q4: 29,617,733 shares; 2025Q1: 29,617,733 shares 29,617,733$407M13.67%0Timeline
ALKTALKAMI TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,520,318 shares; 2024Q4: 9,645,318 shares; 2025Q1: 9,645,318 shares 9,645,318$253M8.5%0Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,233,989 shares; 2024Q4: 5,233,989 shares; 2025Q1: 5,233,989 shares 5,233,989$212M7.11%0Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,681,818 shares; 2024Q4: 9,681,818 shares; 2025Q1: 9,681,818 shares 9,681,818$139M4.67%0Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,531,252 shares; 2024Q4: 7,531,252 shares; 2025Q1: 7,531,252 shares 7,531,252$118M3.97%0Timeline
EWCZEUROPEAN WAX CTR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,110,492 shares; 2024Q4: 13,110,492 shares; 2025Q1: 13,110,492 shares 13,110,492$51.8M1.74%0Timeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,500,000 shares; 2024Q4: 1,500,000 shares; 2025Q1: 1,500,000 shares 1,500,000$46.7M1.57%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,261,684 shares; 2024Q4: 1,261,684 shares; 2025Q1: 1,261,684 shares 1,261,684$37.4M1.26%0Timeline
RSKDRISKIFIED LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,324,998 shares; 2024Q4: 5,324,998 shares; 2025Q1: 5,324,998 shares 5,324,998$24.6M0.83%0Timeline
ACELYRIN INCACELYRIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,889,668 shares; 2024Q4: 2,695,327 shares; 2025Q1: 2,695,327 shares 2,695,327$6.66M0.22%0
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 264,000 shares; 2024Q4: 3,825,952 shares; 2025Q1: 3,825,952 shares 3,825,952$5.82M0.2%0Timeline
CONTEXTLOGIC INCCONTEXTLOGIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 609,616 shares; 2024Q4: 609,616 shares; 2025Q1: 609,616 shares 609,616$4.26M0.14%0
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 936,020 shares; 2024Q4: 2,474,859 shares; 2025Q1: 2,474,859 shares 2,474,859$3.34M0.11%0Timeline

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
THRDTHIRD HARMONIC BIO INC3,372,323$34.7Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950142-25-001365 base2025-05-14acceptance time not in the bulk data set